Cheng-Ping Yu

6PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsContext learningOncology and carcinogenesis not elsewhere classifiedCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Differential Effects of Mesenchymal Stem Cell- and Natural Killer Cell-Derived Extracellular Vesicles on Cisplatin Responsiveness in Endometrial Cancer Cells.

|Jul 06, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

|Sep 04, 2024
An Advanced Machine Learning Model for a Web-Based Artificial Intelligence-Based Clinical Decision Support System Application: Model Development and Validation Study.

Tai-Han Lin, Hsing-Yi Chung, Ming-Jr Jian

|Jul 27, 2022
A Case of Oncocytic Adrenal Cortical Neoplasm with Uncertain Malignant Potential Turned Out to Be Oncocytic Adrenal Cortical Carcinoma with Distant Metastasis: Could Pathology Do Better Initially?

Chien-Peng Huang, Ming-Shen Dai, Chien-Chang Kao

|Feb 25, 2022
Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer.

Cheng-Shuo Huang, Chen-Hua Tsai, Cheng-Ping Yu

|Apr 30, 2021
Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters.

Ying-Si Wu, Jar-Yi Ho, Cheng-Ping Yu

Pageof 1

Frequent Collaborators

3 joint publications

Jar-Yi Ho

2 joint publications

Guo-Shiou Liao

2 joint publications

Jyh-Cherng Yu

2 joint publications

Ming-Shen Dai